Safety, Tolerability, and Immunogenicity of the ACI-24 Vaccine in Adults With Down Syndrome

Authors:

Abstract
Down syndrome (DS) is most often caused by trisomy 21, which results from an extra copy of chromosome 21 that encodes no fewer than 350 genes,1 including APP (OMIM 104760); this gene encodes the amyloid precursor protein, APP, whose cleavage products include the amyloid-β (Aβ) peptide. This process results in generation of excess full-length APP and Aβ. In individuals with DS, diffuse Aβ deposits are visible in the cerebral cortex as early as age 12 years.2 Fibrillar amyloid plaques are observed in almost all individuals with DS after age 40 years.3-5 The lifetime risk of AD among individuals with DS is approximately 90%6; as a result, AD is the leading cause of death among adults with DS older than 35 years.7

This publication has 27 references indexed in Scilit: